BPG is committed to discovery and dissemination of knowledge
Featured Articles
9/4/2018 3:37:14 AM | Browse: 279 | Download: 167
Publication Name World Journal of Experimental Medicine
Manuscript ID 40555
Country of Manuscript Source United Kingdom
2018-06-29 02:01
Peer-Review Started
2018-06-30 07:27
To Make the First Decision
2018-07-17 23:55
Return for Revision
2018-07-18 01:30
2018-07-26 12:28
Second Decision
2018-08-02 12:16
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2018-08-04 21:21
Articles in Press
2018-08-04 21:21
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2018-08-24 06:07
Publish the Manuscript Online
2018-08-30 08:48
ISSN 2220-315x (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Specialty Medicine, Research and Experimental
Manuscript Type Editorial
Article Title Predictive markers of endocrine response in breast cancer
Manuscript Source Invited Manuscript
All Author List Duniya Mosly, Arran Turnbull, Andrew Sims, Carol Ward and Simon Langdon
Funding Agency and Grant Number
Corresponding author Simon Langdon, PhD, Reader (Associate Professor), Cancer Research UK Edinburgh Centre and Division of Pathology Laboratory, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XR, United Kingdom. simon.langdon@ed.ac.uk
Keywords Estrogen; IL6ST; Biomarker; Breast cancer; Predictive
Core Tip The expression level of estrogen receptor remains the major determinant of response for endocrine therapy in breast cancer. Molecular signatures provide increasing confidence for helping identify breast cancers for which endocrine therapy alone is likely to be sufficient. Estrogen and proliferation related genes have come to the fore in many of the molecular signatures. In neo-adjuvant studies, Ki67 expression at baseline and after 2 wk treatment can provide useful prognostic and predictive information. Neo-adjuvant studies continue to seek new markers that relate to tumor response.
Publish Date 2018-08-30 08:48
Citation Mosly D, Turnbull A, Sims A, Ward C, Langdon S. Predictive markers of endocrine response in breast cancer. World J Exp Med 2018; 8(1): 1-7
Url http://www.wjgnet.com/2220-315X/full/v8/i1/1.htm
DOI http://dx.doi.org/10.5493/wjem.v8.i1.1
Full Article (PDF) WJEM-8-1.pdf
Full Article (Word) WJEM-8-1.doc
Manuscript File 40555-Review.docx
Answering Reviewers 40555-Answering reviewers.pdf
Audio Core Tip 40555-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 40555-Conflict-of-interest statement.pdf
Copyright License Agreement 40555-Copyright license agreement.pdf
Peer-review Report 40555-Peer-review(s).pdf
Scientific Misconduct Check 40555-Scientific misconduct check.pdf
Scientific Editor Work List 40555-Scientific editor work list.pdf